Drugs / ERX-963
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03959189 | Jun 2019 → Mar 2020 | myotonic dystrophy type 1 | Expansion Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ERX-963 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03959189 ↗ |